Vera Therapeutics, Inc. (VERA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $354.73M | +282.9% |
| 2024 | $92.65M | +102.8% |
| 2023 | $45.68M | +5.1% |
| 2022 | $43.46M | -45.5% |
| 2021 | $79.67M | +48.5% |
| 2020 | $53.65M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $354.73M | +282.9% |
| 2024 | $92.65M | +102.8% |
| 2023 | $45.68M | +5.1% |
| 2022 | $43.46M | -45.5% |
| 2021 | $79.67M | +48.5% |
| 2020 | $53.65M | — |